The Regulatory Affairs and Compliance Team at BridgeBio oversees the adherence to legal and regulatory standards for developing and delivering breakthrough medicines for genetic diseases. They are responsible for obtaining necessary approvals from health authorities, ensuring compliance with international regulations, managing regulatory submissions, and maintaining lawful operations across global markets. The team also ensures that all activities align with internal policies and industry standards to facilitate the safe and effective distribution of innovative treatments.
View all